Equities

Acen Corp

Acen Corp

Actions
  • Price (USD)0.07
  • Today's Change0.00 / 0.00%
  • Shares traded458.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 22 2024 18:26 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of PHP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments41,63534,67326,514
Total Receivables, Net28,19633,55035,293
Total Inventory9648071,491
Prepaid expenses603348494
Other current assets, total181645482
Total current assets71,57870,02364,272
Property, plant & equipment, net97,14262,12538,174
Goodwill, net21,16421,191247
Intangibles, net5,5967,7452,501
Long term investments59,46547,66748,219
Note receivable - long term18,32319,58714,608
Other long term assets6,59111741
Total assets284,934232,773171,161
LIABILITIES
Accounts payable3,0963,7012,534
Accrued expenses5,1236,2602,517
Notes payable/short-term debt000
Current portion long-term debt/capital leases3,6403,8781,361
Other current liabilities, total8,1853,8581,417
Total current liabilities20,04417,6977,829
Total long term debt83,99564,35242,472
Total debt87,63568,23043,834
Deferred income tax80622674
Minority interest29,90431,86029,951
Other liabilities, total6,7139052,817
Total liabilities141,461115,03983,143
SHAREHOLDERS EQUITY
Common stock39,69239,69238,339
Additional paid-in capital132,296107,49298,044
Retained earnings (accumulated deficit)24,78619,5468,737
Treasury stock - common(29)(29)(29)
Unrealized gain (loss)321212(84)
Other equity, total(53618)(49180)(56989)
Total equity143,472117,73488,018
Total liabilities & shareholders' equity284,934232,773171,161
Total common shares outstanding39,67739,67738,324
Treasury shares - common primary issue151515
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.